Aruna Prabhu

Namakkal, TN, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Ca125 KELIM as a Potential Tool for Predicting Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Benefit at Interval Cytoreductive Surgery for Advanced Epithelial Ovarian Cancer-A Propensity Score-Matched Analysis.

Ca125 KELIM as a Potential Tool for Predicting Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Benefit at Interval Cytoreductive Surgery for Advanced Epithelial Ovarian Cancer-A Propensity Score-Matched Analysis.

Journal: Journal of surgical oncology

Published: October 02, 2025

Stromal Tumor infiltrating lymphocytes (sTILs) as a prognostic biomarker in Ovarian Cancer After Neoadjuvant chemotherapy.

Stromal Tumor infiltrating lymphocytes (sTILs) as a prognostic biomarker in Ovarian Cancer After Neoadjuvant chemotherapy.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: August 21, 2025

The INDEPSO-ISPSM Consensus on Peritoneal Malignancies-Gastric Cancer Peritoneal Metastases.

The INDEPSO-ISPSM Consensus on Peritoneal Malignancies-Gastric Cancer Peritoneal Metastases.

Journal: Indian journal of surgical oncology

Published: March 10, 2025

The INDEPSO-ISPSM Consensus on Peritoneal Malignancies-Mucinous Appendiceal Neoplasms and Pseudomyxoma Peritonei.

The INDEPSO-ISPSM Consensus on Peritoneal Malignancies-Mucinous Appendiceal Neoplasms and Pseudomyxoma Peritonei.

Journal: Indian journal of surgical oncology

Published: September 12, 2024

The INDEPSO-ISPSM Consensus on Peritoneal Malignancies-Methodology.

The INDEPSO-ISPSM Consensus on Peritoneal Malignancies-Methodology.

Journal: Indian journal of surgical oncology

Published: September 11, 2024

Cytoreductive Surgery With or Without HIPEC in the Management of Peritoneal Dissemination from Rare Histological Subtypes of Ovarian Cancer - a Retrospective Study by INDEPSO.

Cytoreductive Surgery With or Without HIPEC in the Management of Peritoneal Dissemination from Rare Histological Subtypes of Ovarian Cancer - a Retrospective Study by INDEPSO.

Journal: Indian journal of surgical oncology

Published: July 04, 2022

Closing the Cancer Care Gap in India.

Closing the Cancer Care Gap in India.

Journal: Indian journal of surgical oncology

Published: May 19, 2022

Gastric Cancer With Peritoneal Metastasis-A Comprehensive Review of Current Intraperitoneal Treatment Modalities.

Gastric Cancer With Peritoneal Metastasis-A Comprehensive Review of Current Intraperitoneal Treatment Modalities.

Journal: Frontiers in oncology

Published: January 31, 2022

Intraperitoneal chemotherapy in the treatment of gastric cancer peritoneal metastases: an overview of common therapeutic regimens.

Intraperitoneal chemotherapy in the treatment of gastric cancer peritoneal metastases: an overview of common therapeutic regimens.

Journal: Journal of gastrointestinal oncology

Published: May 10, 2021

Retrospective Analysis of Patients with Signet Ring Subtype of Colorectal Cancer with Peritoneal Metastasis Treated with CRS & HIPEC.

Retrospective Analysis of Patients with Signet Ring Subtype of Colorectal Cancer with Peritoneal Metastasis Treated with CRS & HIPEC.

Journal: Cancers

Published: July 04, 2020

Neoadjuvant Intraperitoneal Chemotherapy in Patients with Pseudomyxoma Peritonei-A Novel Treatment Approach.

Neoadjuvant Intraperitoneal Chemotherapy in Patients with Pseudomyxoma Peritonei-A Novel Treatment Approach.

Journal: Cancers

Published: June 30, 2020

First Report of a Low-Grade Pseudomyxoma peritonei Originating from Gall Bladder.

First Report of a Low-Grade Pseudomyxoma peritonei Originating from Gall Bladder.

Journal: Visceral medicine

Published: April 28, 2020

Showing 1-12 of 18

Last Updated: 09/26/2026